CD38‐Targeted Theranostics of Lymphoma with (89)Zr/(177)Lu‐Labeled Daratumumab

Lymphoma is a heterogeneous disease with varying clinical manifestations and outcomes. Many subtypes of lymphoma, such as Burkitt′s lymphoma and diffuse large B cell lymphoma, are highly aggressive with dismal prognosis even after conventional chemotherapy and radiotherapy. As such, exploring specif...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Adv Sci (Weinh)
Main Authors: Kang, Lei, Li, Cuicui, Rosenkrans, Zachary T., Huo, Nan, Chen, Zhao, Ehlerding, Emily B., Huo, Yan, Ferreira, Carolina A., Barnhart, Todd E., Engle, Jonathan W., Wang, Rongfu, Jiang, Dawei, Xu, Xiaojie, Cai, Weibo
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2021
Assuntos:
Full Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8132161/
https://ncbi.nlm.nih.gov/pubmed/34026426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202001879
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares